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Standard operating procedures (SOP) in experimental stroke research: 
SOP for middle cerebral artery occlusion in the mouse 
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Thus far, the translation of promising results from preclinical stroke research into effective clinical 
therapy has not met with success (1). Among the numerous possible reasons for this failure, quality 
problems in some of the basic research or preclinical studies have to be considered. False-positive 
results, inflated effect sizes, and marginal reproducibility may have overestimated or even affected 
the potential of novel stroke therapeutics (2). Systematic reviews have found quantitative evidence 
that low study quality may have introduced a bias into preclinical stroke research (3,4,5). As opposed 
to many other causes of the 'translational roadblock', study quality is fully under the control of the 
researcher, and thus a prime target for improvement. Increasingly, funding bodies and review boards 
overseeing animal experiments are taking a proactive stance, and demand auditable measures of 
quality control in preclinical research (6). The Stroke Therapy Academic Industry Roundtable 
(STAIR) recently updated its recommendations for the evaluation of preclinical data on 
neuroprotective drugs (7) to include good laboratory practice (GLP) issues (8). 
Monitoring, auditing, and standard operating procedures (SOPs) are key elements of quality control 
in randomized clinical trials (RCTs). It has been proposed that experimental stroke research adapt 
some of the tools used in clinical stroke research. In particular, stroke laboratories should set up and 
publish their SOPs (e.g., on their institutional websites), and guarantee that their studies adhere to 
these standards (9). This is all the more important, as a certain portion of their experiments, 
evaluations, etc. are not performed by professionals, but rather by students in training who are 
unaware of these issues.  
 
A standard operating procedure (SOP) is a set of instructions with the force of a directive covering 
those features of operations that lend themselves to a definite or standardized procedure without 
loss of effectiveness. The primary purpose of an SOP in experimental stroke research is to guide 
and standardize working procedures in order to ensure data reliability and integrity. It is crucial that 
researchers, students and technicians read and follow the SOPs. If this is not the case, SOPs will 
not only fail to achieve their goal; they will also engender a false sense of security. Failures are often 
due to technical shortcomings in the SOPs themselves. SOPs should be written by the user, as they 
must convey a clear instruction. The user must not only understand the instruction but also be 
prepared to carry it out.  
  
We in the following introduce for the first time an SOP in experimental stroke research.  
Write down what you do, do what is written down! 
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SOP - Middle cerebral artery occlusion (MCAO) in the mouse  
(intraluminal suture)  
 
 
1 Aim  
Experimental induction of focal cerebral ischemia after occlusion of the middle cerebral artery in 
mice. Applies to a procedure in a standard lab equipped and certified for in vivo experimentation in 
mice (including anaesthesia with volatile anaesthetics). Experimental procedures require approval 
by the relevant committees.  
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2 Background  
Experimental focal ischemia is most commonly studied after permanent or transient occlusion of the 
middle cerebral artery (MCA) in rodents. Proximal MCA occlusion can be induced by an intraluminal 
suture (so-called filament model) and causes injury to cortex and deeper brain structures (striatum). 
Distal MCA occlusion (the so-called 'Brint' or 'Tamura'-models) is usually produced by blocking the 
MCA after it gives off lencticulostriate branches at the basal surface of the lateral part of the cerebral 
hemisphere.  Distal occlusion typically spares the striatum and primarily involves the neocortex. If 
recirculation is established early (2 hrs or less) outcome is better (transient MCA occlusion). In some 
ways, the reperfused brain imitates restoration of blood flow after spontaneous lysis of a 
thromboembolic clot in humans, even though reperfusion after clot lysis is certainly more complex 
than an on-off phenomenon as modelled by placement and retraction of an intravascular filament. 
 
 
3 Scope  
Department of Experimental Neurology (all employees) 
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4 Process description  
 
4.1 Materials & Instrumentation 
• Ready coated MCAo filaments, e.g. Doccol® or 8/0 nylon monofilament for coating with 
silicone gel with hardener (e.g. Xantopren®) 
• surgical thread 4/0- 7/0  
• surgical needle and thread for skin suture  
• dissecting microscope (max. x 40) 
• temperature feedback controlled heating plate 
• surgical instruments 
• forceps (e.g. Dumont Medical #5 straight tip 0,05mm x 0,02 mm) 
• surgical scissors (skin cut)  
• forceps for skin handling and suture (e.g. standard anatomical) 
• vascular spring scissors (e.g. Vannas) 
• absorbing material (e.g. swab) 
• Micro vascular clamp (e.g. S&G B1-V) and applying forceps 
• Needle holder (e.g. Olsen-Hegar or other) 
• anaesthesia system for isoflurane, oxygen and nitrous oxide 
• heated recovery cage 
4.2 Cautions 
Maintain a body temperature of 37.0 +/- 0.5 °C during occlusion and after reperfusion (for 2 hours).  
Ensure proper pain relief in the perioperative and postoperative period, e.g. by repeated topical 
application of a long-acting local anaesthetic, for instance bupivacaine ointment serving as an 
absorption depot.  
For specific details see Maximising animal welfare in experimental rodent stroke SOP.   
Surgical procedures should be carried out under clean conditions. (disinfected surgical instruments 
and materials, clean gown, gloves, etc.). See Aseptic technique and anaesthesia SOP and Appendix 
below. 
 
4.3 Personnel and Qualifications 
In general, surgeons need: 
• general supervision and instruction 
• the appropriate certification 





1. Mice are anaesthetized with 1.5-3.5% Isoflurane and maintained in 1.0-2.5% Isoflurane with 
approximately 75/25 N2O/O2. For additional analgesic treatment follow the Maximizing animal 
welfare in experimental rodent stroke SOP.2. The use of any non-invasive physiological 
monitoring available locally (e.g. Laser Doppler) is recommended  
3. Maintain body temperature at 37.0 +/- 0.5 °C using a heating plate or homoeothermic blanket 
system. 
4. Place the mouse in supine position. Disinfect the skin of the ventral neck. 
 
MCAO Surgery:   
5. In our lab the left MCA will be occluded routinely. Right MCA occlusion is also permitted. Left or 
right must be defined in advance and reported with your data. Reasons to change sides could 
be planned behavioural experiments to determine functional outcome more robustly, like paw 
preference or the handedness of the surgeon. The following procedure describes left MCA 
occlusion. 
6. A midline neck incision is made and the soft tissues are pulled apart. 
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7. The common carotid artery (CCA) is carefully dissected free from the surrounding nerves (without 
harming the vagus nerve) and a ligature is made using suture thread. 
8. Then the external carotid artery (ECA) on the same side is separated and a second knot is made. 
9. Next, the internal carotid artery (ICA) is isolated and a loose knot is prepared with a suture thread. 
10. After obtaining good view of the internal carotid artery (ICA) and the pterygopalatine artery (PA), 
both arteries are clipped. 
11. A small hole is cut in the CCA before it bifurcates to the ECA and the ICA. 
12. A Doccol® filament or a monofilament made of 8/0 nylon coated with silicon hardener mixture is 
then introduced into the artery. Doccol® filaments should be disinfected with 70% ethanol or 
sterilized with ethylene oxide. Alternative filaments should be sterilized according to local 
protocol.  
13. The clipped arteries are opened while the filament is inserted into the ICA to occlude MCA.  
14. The third knot on the ICA is closed to fix the filament in position. 
15. Ischemia is confirmed by Laser Doppler flowmetry, MRI, or by withdrawing general anaesthesia 
and checking for neurological deficit according to local protocols, like circling behaviour during 
occlusion time, and twisting of the mice when held by the tail. 
16. The mice are allowed to recover in the heated recovery cage at thermoneutral temperature (30-
31°C) for the duration of the MCA occlusion. 
17. After X min/hours occlusion, the mice are re-anaesthetized and the third knot is opened and the 
filament withdrawn (if reperfusion is intended). 
18. The remaining threads are cut and the skin is adapted with a surgical suture 
19. Rehydration and pain relief. Refer to the Maximizing animal welfare in experimental rodent stroke 
SOP and follow one of the recommended protocols. 
 
Sham procedure: 
For sham operations the filament is inserted to occlude the MCA and withdrawn immediately to allow 
instant reperfusion (12.). The subsequent operation is identical to the animals undergoing 
cerebral ischemia (13.- 19.).  
 
A video is available which demonstrates the above described procedure. (see reference 10) 
 
5 Evaluation / Control 
no record  
 
6 Modification  




description of modification 
2, 4, 7 Clarification of procedures 
  
 
7 Appendix to SOP 
1. Entry qualification experiment for mouse MCAO surgeons: 
New surgeons need to demonstrate in a series of experiments that they perform the MCAO-
operation within 15 minutes. Reproducibility is verified by induction of a certain infarct volume within 
a standard deviation of 40%. Mortality must not exceed 10% within 24 hours.  
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2. Randomized selection of animals from cage and concealment of treatment allocation 
 
2 a. Pharmacological study: Animals in cage are marked with an identity code at the beginning of 
the procedure. Computer program (random number generator) selects animal, and assigns it to 
concealed treatment arm ('A', 'B', etc.). 
Stock solution or pharmaceutical ready for application is prepared by assistant and randomly 
assigned code ('A', 'B', etc.). 
 
2 b. Genetically manipulated animals: Animals in both cages (e.g. knockout / wildtype) are marked 
with bar/dot code at the beginning of the procedure. Computer program (random number generator) 
selects animal and assigns it to concealed experimental arm ('A', 'B', etc.). Blinded intervention 
whenever possible.  
 
3. Temperature control: 
The body temperature of mice during surgery is maintained at 37.0 +/- 0.5 °C using a temperature-
controlled heating plate. Maintain a body temperature of 37.0 +/- 0.5 °C also after reperfusion (for 2 
hours) using a heated recovery box set at thermoneutral temperature (30-31°C). 
 
4. Outcome assessment 
Infarct volume should be evaluated blinded. Functional outcome, including a battery of tests to detect 
sensorimotor deficits should be assessed as well. Mortality and exclusion of animals have to be 
reported, including specific causes for exclusion.  
 
For exclusion follow the main criteria: 
No stroke, indicated by absence of functional deficit like circling behaviour during occlusion time, 
Insufficient Doppler flow reduction or missing functional deficit or missing infarct in MRI (DWI or T2) 
at 24h after MCAo. 
Insufficient or non-existent reperfusion (insufficient restoration of Doppler flow). 
Technical problems during induction of MCAo (excessive bleeding, prolonged operation time > 15 
min, thread misplacement). 
CAVE: 
Especially in genetically manipulated animals, be aware of vascular alterations, which might directly 
affect stroke outcome 
 
5. Physiological parameters: 
Mean arterial blood pressure (MABP), heart rate (HR), blood gases, CBF should be measured in 
selected animals. 
 
6. Quasi-sterile surgery 
Prior to surgery, the surgeon has to clean his hands. The surgeon has to wear a lab coat, during 
surgery and it is advisable to wear hat, surgical mask and non-sterile gloves at all times the animal 
is being handled. If gloves cannot be used, a surgical hand disinfection should precede the operation.  
The necessary components of aseptic techniques in rodents include also disinfected instruments, 
and separate surgical and animal prep areas. The use of glass bead sterilizer for re-sterilization of 
instruments during for repetitive procedures is recommended. 
 
• Instruments should be kept clean and sterile prior surgery (either by placing in 70% ethanol 
or a glass bead sterilizer for the appropriate period of time for the method used to be 
effective).  
• Separate instruments should be used for skin and tissue handling. 
• Instruments should be cleaned of blood and debris between surgeries. (Best: distilled water) 
• If contamination has occurred, instruments must be cleaned between animals. Surgical 
gloves and blades should be changed after contamination.  
• Following surgery all instruments must be thoroughly cleaned. 
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